1-27370346-G-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_003665.4(FCN3):c.658+250C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.267 in 484,418 control chromosomes in the GnomAD database, including 19,404 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as risk factor (no stars).
Frequency
Genomes: 𝑓 0.25 ( 5311 hom., cov: 32)
Exomes 𝑓: 0.28 ( 14093 hom. )
Consequence
FCN3
NM_003665.4 intron
NM_003665.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.403
Publications
12 publications found
Genes affected
FCN3 (HGNC:3625): (ficolin 3) Ficolins are a group of proteins which consist of a collagen-like domain and a fibrinogen-like domain. In human serum, there are two types of ficolins, both of which have lectin activity. The protein encoded by this gene is a thermolabile beta-2-macroglycoprotein found in all human serum and is a member of the ficolin/opsonin p35 lectin family. The protein, which was initially identified based on its reactivity with sera from patients with systemic lupus erythematosus, has been shown to have a calcium-independent lectin activity. The protein can activate the complement pathway in association with MASPs and sMAP, thereby aiding in host defense through the activation of the lectin pathway. Alternative splicing occurs at this locus and two variants, each encoding a distinct isoform, have been identified. [provided by RefSeq, Jul 2008]
FCN3 Gene-Disease associations (from GenCC):
- immunodeficiency due to ficolin3 deficiencyInheritance: AR Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.323 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.247 AC: 37467AN: 151972Hom.: 5310 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
37467
AN:
151972
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.277 AC: 91900AN: 332328Hom.: 14093 AF XY: 0.272 AC XY: 47662AN XY: 175072 show subpopulations
GnomAD4 exome
AF:
AC:
91900
AN:
332328
Hom.:
AF XY:
AC XY:
47662
AN XY:
175072
show subpopulations
African (AFR)
AF:
AC:
1159
AN:
10160
American (AMR)
AF:
AC:
2592
AN:
11730
Ashkenazi Jewish (ASJ)
AF:
AC:
4165
AN:
10430
East Asian (EAS)
AF:
AC:
2618
AN:
23130
South Asian (SAS)
AF:
AC:
5596
AN:
33836
European-Finnish (FIN)
AF:
AC:
5208
AN:
20892
Middle Eastern (MID)
AF:
AC:
477
AN:
1466
European-Non Finnish (NFE)
AF:
AC:
64691
AN:
201356
Other (OTH)
AF:
AC:
5394
AN:
19328
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
3029
6058
9086
12115
15144
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
294
588
882
1176
1470
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.246 AC: 37472AN: 152090Hom.: 5311 Cov.: 32 AF XY: 0.242 AC XY: 18022AN XY: 74344 show subpopulations
GnomAD4 genome
AF:
AC:
37472
AN:
152090
Hom.:
Cov.:
32
AF XY:
AC XY:
18022
AN XY:
74344
show subpopulations
African (AFR)
AF:
AC:
5016
AN:
41492
American (AMR)
AF:
AC:
3710
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
AC:
1448
AN:
3470
East Asian (EAS)
AF:
AC:
617
AN:
5178
South Asian (SAS)
AF:
AC:
804
AN:
4826
European-Finnish (FIN)
AF:
AC:
2664
AN:
10564
Middle Eastern (MID)
AF:
AC:
99
AN:
294
European-Non Finnish (NFE)
AF:
AC:
22196
AN:
67964
Other (OTH)
AF:
AC:
589
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1391
2782
4174
5565
6956
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
404
808
1212
1616
2020
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
469
AN:
3478
ClinVar
Significance: risk factor
Submissions summary: Other:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
Rheumatic heart disease Other:1
Jan 09, 2019
Biochemistry and Molecular Biology, Faculty of Pharmacy, Al-Azhar University
Significance:risk factor
Review Status:no assertion criteria provided
Collection Method:case-control
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.